Cargando…
Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette–Guérin
Mycobacterium bovis bacille Calmette–Guérin (BCG) is listed as an intralesional (IL) therapeutic option for inoperable stage III in-transit melanoma in the National Comprehensive Cancer Network Guidelines. Although the mechanism is unknown, others have reported up to 50% regression of injected lesio...
Autores principales: | Yang, Junbao, Jones, Maris S., Ramos, Romela Irene, Chan, Alfred A., Lee, Agnes F., Foshag, Leland J., Sieling, Peter A., Faries, Mark B., Lee, Delphine J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380679/ https://www.ncbi.nlm.nih.gov/pubmed/28424760 http://dx.doi.org/10.3389/fonc.2017.00061 |
Ejemplares similares
-
Mycobacterium bovis Bacillus Calmette–Guérin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function
por: Lardone, Ricardo D., et al.
Publicado: (2017) -
γδ T cell activation may contribute to antitumor immunity stimulated by intralesional BCG immune therapy for cutaneous melanoma metastases
por: Ramos, Romela, et al.
Publicado: (2015) -
Mycobacterium bovis Bacille-Calmette-Guérin Infection Aggravates Atherosclerosis
por: Huaman, Moises A., et al.
Publicado: (2020) -
3280 Mycobacterium bovis Bacille-Calmette-Guérin infection aggravates atherosclerosis
por: Huaman, Moises, et al.
Publicado: (2019) -
Mycobacterium bovis Osteitis Following Immunization with Bacille Calmette-Guérin (BCG) in Korea
por: Choi, Youn Young, et al.
Publicado: (2018)